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Abstract
The small molecule biosynthetic potential of most filamentous fungi remains largely unexplored 
and represents an attractive source for new compound discovery. Genome sequencing of 
Calcarisporium arbuscula, a mushroom endophytic fungus, revealed 68 core genes that are 
involved in natural products biosynthesis. This is in sharp contrast to predominant production of 
the ATPase inhibitors aurovertin B (1) and D (2). Inactivation of a histone H3 deacetylase HdaA 
led to pleiotropic activation and overexpression of more than 75% of the biosynthetic genes. 
Sampling of the overproduced compounds led to isolation of ten compounds of which four contain 
new structures, including the cyclic peptides arbumycin (3) and arbumelin (4); the diterpenoid 
arbuscullic acid A (11); and a meroterpenoid arbuscullic acid B (12). Such epigenetic modification 
therefore provides a rapid and global approach to mine the chemical diversity of endophytic fungi.
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Filamentous fungi are prolific producers of bioactive natural products,[1] exemplified by the 
antibiotic penicillin[2] and the anti-hypercholesteromia lovastatin.[3] Recent genome 
sequencing efforts of many fungal species have revealed significant biosynthetic potential, 
as represented by a large number of cryptic and diverse biosynthetic pathways.[4] Synthetic 
biological efforts to activate these silent pathways in well-studied fungal species, mostly in 
the Penicillium and Aspergillus genera, have led to the discovery of new natural products.[5] 
In particular, epigenetic approaches that lead to chromatin remodeling have resulted in 
activation of individual gene clusters.[6]
Endophytic fungi are increasingly recognized as significant underachievers in natural 
product biosynthesis.[7] For example, recent genome sequencing of entomophytic fungus 
Metarhizium anisopliae and endophytic fungus Beauveria bassiana revealed each encodes a 
large number of potential secondary metabolite gene clusters (85 and 45, respectively), 
significantly more than the number of compounds that has been reported for each strain.[8] 
Such high biosynthetic potential is a reflection of the complex natural ecological 
environment,[9] which is difficult to replicate in the laboratory, resulting in most gene 
clusters being silent in axenic cultures. Therefore, genetically modifying endophytic fungi to 
activate, ideally globally, the plethora natural product pathways can be particularly fruitful 
in accessing new chemical scaffolds.
Calcarisporium arbuscula is an endophytic fungus living in the fruiting bodies of 
mushrooms.[10] Fungi in the Calcarisporium genus have been noted for production of a few 
antimicrobials and mycotoxins.[11] C. arbuscula predominantly produces F1-ATPase 
inhibitors 1 and 2, which are polyketides containing an unusual 2,6-
dioxabicyclo[3.2.1]octane core connected to an α-pyrone through a triene linker (Scheme 
1).[12] Bioinformatics analysis of the draft genome sequence of C. arbuscula showed 68 
gene clusters encoding potential natural product biosynthetic pathways, among which 41 
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contain polyketide synthases (PKSs) (including 4 PKS-nonribosomal peptide synthetase 
(NRPS) hybrids), 18 contain NRPSs and 9 contain terpene synthases (TS) (Table S1–S3). 
This large collection of biosynthetic gene clusters is in sharp contrast to the two 
predominant metabolites 1 and 2 (Figure 1).[12a] This organism therefore represents a prime 
resource for genome mining using globally effective approaches. However, initial attempts 
to culture the fungus on different media, such as MEPA, CYA, YMEG or YG, did not lead 
to production of new compounds. The nongenetic strategy of addition DNA 
methyltransferase inhibitor 5-azacytidine or histone deacetylase (HDAC) inhibitor suberoyl 
bis-hydroxamic acid[13] also did not change the metabolomic profile.
In filamentous fungi, many silenced gene clusters are located within the heterochromatic 
regions and subsequently transcriptionally repressed.[14] HDACs remove acetyl groups from 
the amino-tails of histones and maintain the chromatin in an inaccessible state for the 
transcriptional machinery.[15] Keller and coworkers showed that fungal HDACs negatively 
regulate production of sterigmatocystin and penicillin in A. nidulans; and attenuate 
transcription of NRPS gene clusters in A. fumigatus.[16] To investigate the roles of HDACs 
in C. arbuscula, we deleted hdaA (Figure S3), which encodes the histone H3 lysine 14 
(K14) deacetylase. Removal of hdaA resulted in slower growth, shorter mycelia and 
defective sporulation in C. arbuscula (Figure S4). Metabolite extraction and LC/MS analysis 
revealed production of significantly more compounds compared to the wild type (Figure 1). 
Comprehensive RT-PCR analysis of all 68 core biosynthetic genes showed that while weak 
to no expression of most core genes were observed in wild type, deletion of hdaA led to 
increased expression of 75% (31/41) of the PKS genes, 78% (14/18) of the NRPS genes and 
78% (7/9) of the TS genes (Figure S5). Hence, C. arbuscula HdaA globally suppresses 
biosynthetic genes under axenic growth conditions and its deletion leads to pleiotropic 
activation of secondary metabolism.
To characterize the newly produced compounds in the ΔhdaA strain, the organic extracts 
were partitioned with n-hexane and methanol. Then the methanol phase was fractionated by 
reversed phase chromatography. Four fractions particularly rich in metabolites were selected 
for further purification, which led to the isolation of 10 compounds, including three peptides 
(3, 4, 5), three polyketides (6, 7, 8), three diterpenes (9, 10, 11) and one polyketide-diterpene 
hybrid (12). Among them, 3, 4, 11 and 12 are new (Scheme 1).
Two new cyclic peptides arbumycin (3) (10 mg/L) and arbumelin (4) (0.17 mg/L), and a 
lipopeptide verlamelin A (5) (0.25 mg/L) were isolated from the ΔhdaA mutant. When 
selective ion monitoring was performed, a ten-fold decrease in the level of 3 can be detected 
in the wild type, and no trace of 4 or 5 could be found (Figure 3a). The structure of 3 was 
elucidated as a cyclic penta-depsipeptide based on NMR spectra (Table S11, Figure S13–
S18) and X-ray crystallography (Figure S6). The asymmetric peptide is derived from three 
amino acids (L-Ala, L-Thr, L-Ile) and two identical hydroxyl acids (2S,3R)-2-hydroxy-3-
methylpentanoic acid 13 (Figure 2c). Most fungal depsipeptides characterized to date are 
symmetrical and are catalyzed by the iterative action of a two module NRPS depsi-peptide 
synthase.[17] Therefore, the asymmetrical nature of 3 presents an interesting case of structure 
variation in this family. The (2S,3R) stereochemistry in 13 was an unexpected finding from 
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the crystal structure, and indicates possible epimerization of the 3R methyl group from (2S,
3S)-isoleucine.
To understand the biosynthesis of 3, we identified a potential cluster on scaffold 82 that 
consists of a five module NRPS (ArbA) and an aldo-ketoreductase (ArbB) (Figure 2a). The 
transcription level of arbA is increased in the ΔhdaA strain (Figure 3b). While ArbA 
contains a C-terminal condensation domain (CT) consistent with formation of a cyclic 
product,[18] the last module (module 5) did not contain an adenylation (A) domain. This 
indicates module 5 may use the same substrate (13 is used twice in 3) as a previous module 
and an A domain may be shared between the two modules. Sequence analysis of the 10-
amino acid specificity codes of A domains revealed that A2 should be responsible for 
incorporation of 13, as the highly conserved Asp235 that anchors the amino groups of amino 
acids is replaced by Ala235; while a threonine (Thr330) conserved in hydroxyacid-
activating A domains is present (Table S4).[17] Indeed, inactivation of arbA in wild type C. 
arbuscula (Figure S7) completely abolished the production of 3 (Figure 2b). The proposed 
biosynthesis of 3 from ArbA and ArbB is shown in Figure 2c. We suggest that ArbB may be 
responsible for the ketoreduction and epimerization of 2-keto-3S-pentanoic acid to yield 13. 
This is highly reminiscent of the epimerizing ketoreductase (KR) domains found in bacterial 
type I PKSs, in which the KR domains are able to control the stereochemistry at vicinal α-
methyl and β-hydroxyl substituted carbons starting from α-methyl-β-ketone substrates.[19]
Arbumelin 4 is a new cyclic nonapeptide containing three Gly and two D-amino acids as 
characterized by NMR (Table S12–S13, Figure S19–S27). The stereochemical 
configurations of the constituent amino acids were determined through hydrolysis, 
derivatization and HPLC analysis (Supporting Information). One nine-module NRPS on 
contig 453 is proposed to be the candidate for the biosynthesis of 4. Sequence analysis 
showed that the 10-amino acid specificity code of A domains in module 3, 7 and 8 are 
nearly identical and consistent with three Gly positions in 4 (Table S5). The E domains in 
modules 4 and 5 should be responsible for the epimerization of the consecutive DO-methyl-
Tyr and D-Val. Taken together, the linear sequence of 4 is likely to be L-Leu-L-Tyr-Gly-D-
O-methyl-Tyr-D-Val-L-Ser-Gly-Gly-L-Val, which is macrocyclized by the terminal CT 
domain in the NRPS (Scheme S1).[18] Immediately adjacent to the NRPS gene is a gene 
encoding a methyltransferase (Figure S8). It may be responsible for formation of the O-
methyl-Tyr residue prior to activation by module 4. 5 was solved by extensive NMR 
spectroscopy (Figure S27–S31) and is the same as a recently reported cyclic hexa-
lipopeptide verlamelin, an antifungal compound isolated from Lecanicillium sp. HF627.[20] 
The corresponding gene cluster is located on contig 1462 with the same set of genes (such as 
NRPS, fatty acyl ligase, etc) as reported for verlamelin (Figure S8).[20] The NRPS-encoding 
genes on contig 453 and 1462 were verified to be overexpressed in the ΔhdaA mutant 
(Figure 3b).
Deletion of hdaA led to a twenty-fold increase in the level of the mycotoxin sterigmatocystin 
(6) (Figure 3a). The activated gene cluster on contig 1693 is readily identified based on 
>70% sequence identity to that from Aspergillus ochraceoroseus (Figure S1).[21] 
Overexpression of this pathway (Figure 3b) also led to the isolation of the protein tyrosine 
kinase inhibitors paeciloquinone A (7) and B (8) (Figure S33–S34), which are shunt 
Mao et al. Page 4













products of the biosynthetic pathway of 6 (Scheme S2).[22] Bioinformatic analysis of 
remaining PKS gene clusters also revealed the potential to produce other mycotoxins such as 
citrinin (contig921) (Figure S2).[23]
The ΔhdaA strain produced three labdane-related diterpenoid compounds (9-11) as 
characterized by NMR (Table S14, Figure S35–S44). Upon structure elucidation, 9 (0.67 
mg/L) and 10 (0.23 mg/L) were confirmed to be the isocassadienes zythiostromic acid A and 
B, respectively.[24] Both compounds are heavily oxidized derivatives of isocassadiene 
14.[25] The new diterpene arbusculic acid A (11) is structurally related to 9 and 10, and most 
likely derives from cassadiene 15 (Scheme 2). 11 contains a dienol functional group that has 
not been observed in fungal diterpenoids. Because of their structural similarities, we propose 
that compounds 9-11 are synthesized from the same diterpene biosynthetic gene cluster. 
BLAST search against pimaradiene synthase from A. nidulans (AN1594)[26] and ent-
kaurene synthase from the fungus Phaeosphaeria sp. L487[27] revealed a diterpene synthase 
with the highest identity on contig 1936 (Figure S9a). Based on structural modeling against 
the taxadiene synthase from Taxus brevifolia,[28] this C. arbuscula diterpene cyclase is 
organized in three α-helix domains, including two class I and one class II domains (Figure 
S10b, c).[28] This gene was highly transcribed in the mutant strain compared to the wild type 
(Figure 3b). Also found in the gene cluster are two adjacent P450 with sequence similarity 
to ent-kaurene oxidases (Figure S10).[27] The proposed mechanism of formation of 11 is 
shown in Scheme 2, in which 15 is first epoxidized at the terminal olefin followed by acid-
catalyzed ring-opening hydrolysis with transposition of the diene to yield 16. Both 15 and 16 
can be subjected to multiple hydroxylations at C3 and C5, as well as six-electron oxidation 
at C19 to yield 9 and 11, respectively. Intriguingly, we also isolated a meroterpenoid 
compound arbuscullic acid B (12) (0.2 mg/L) from the ΔhdaA mutant (Table S15, Figure 
S45–S49). 12 is derived from the esterification of 11 to the carboxylic acid moiety of 
paeciloquinone D (17),[22a] which is the free acid form of the lactone 7, through the C3 
hydroxyl group. The regioselectivity of the ester linkage was confirmed by extensive 2D 
NMR spectroscopy (Table S15), while no alternatively esterification regioselectivity 
between 11 and 17 was detected. This suggests the coupling of 11 and 17 may be enzyme 
catalyzed instead of from a nonenzymatic reaction.
In summary, deletion of a single HDAC gene in the endophytic C. arbuscula led to the 
global alteration of secondary metabolism and pleiotropic production of new natural 
products of different chemotypes and biosynthetic origins. Continued chemical isolation 
from this strain, along with additional regulatory engineering efforts, can lead to the 
enhanced realization of the biosynthetic potential of this and other endophytic fungi.
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HPLC contour plot of extracts from WT and the ΔhdaA C. arbuscula strains. The boxed 
region contains compounds 3-12 isolated in this work.
Mao et al. Page 8














Characterization of arbumycin (3) and its gene cluster in C. arbuscula. a) The putative gene 
cluster for the biosynthesis of 3; b) Genetic verification of the gene cluster for the 
biosynthesis of 3; c) A proposed pathway for the biosynthesis of 3.
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Over-production of compounds in the ΔhdaA mutant. a) Higher yields of compounds 3-9, 11 
and 12 in the ΔhdaA mutant based on EIC compared to 1. b) RT-PCR analysis of gene 
expression of the selected core genes. The housekeeping actA served as the internal control. 
The contig numbers (with corresponding compounds in the parentheses) are also shown.
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Compounds purified from C. arbuscula. Compounds 1 and 2 are from wild type, and 3-12 
are from the ΔhdaA mutant.
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Proposed pathways for the biosynthesis of 9-12.
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